Cost analysis of adjuvant therapy with XELOX or FOLFOX4 for colon cancer
Author:
Affiliation:
1. Department of Medical Oncology; Cancer Center; Sichuan University; Chengdu; China
2. State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu; China
Publisher
Wiley
Subject
Gastroenterology
Reference17 articles.
1. Multi-center phase II study of modified FOLFIRI in patients in a Chinese population with advanced colorectal cancer (CRC) refractory to fluoropyrimidine and oxaliplatin;Zhang;2005 ASCO Annual Meeting Proceedings, J Clin Oncol,2005
2. Follow-up of patients with colorectal cancer: numbers needed to test and treat;Kievit;Eur J Cancer,2002
3. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer;Chau;Ann Oncol,2005
4. Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;Thierry;N Engl J Med,2004
5. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer;Daniel;J Clin Oncol,2011
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost-effectiveness of different chemotherapy strategies for high-risk stage II colon cancer;World Chinese Journal of Digestology;2023-09-08
2. Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review;Cost Effectiveness and Resource Allocation;2023-01-31
3. Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English;Applied Health Economics and Health Policy;2021-07-29
4. Direct costs associated with the management of mucositis: A systematic review;Oral Oncology;2021-07
5. Cost-effectiveness analysis of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced esophageal squamous cell carcinoma based on the NEOCRTEC5010 trial;Radiotherapy and Oncology;2019-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3